Lysinibacillus sphaericus 拉丁名
(ATCC? 13805?)統一編號
Deposited As Bacillus lentus Gibson
Strain Designations 別名 MB 284
Application 用途 Hydroxylates sclareol
Produces 1,4-diene-3-ketosteroids
Transforms isopinocampheol
Isolation 分離基物 Soil
Biosafety Level 生物安全等級 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format 提供形式 freeze-dried
Preceptrol? no
Type Strain 模式菌種 no
Comments 注釋 Uv-induced mutant
Medium 培養(yǎng)基 ATCC? Medium 225: Beef extract medium
Growth Conditions 生長條件
Temperature 培養(yǎng)溫度: 37°C
Name of Depositor 寄存者 Schering, Inc.
U.S. Patent Number 3,102,080
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Isolation 分離基物 Soil
References 參考文獻 Raspe G, et al. Method of producing 1,4-diene-3-ketosteroids. US Patent 3,102,080 dated Aug 27 1963
Z. Naturforsch. Sect. C Biosci. 49: 553-560, 1994.
Wolf-Rainer A. Microbial hydroxylation of sclareol. Phytochemistry 36: 1421-1424, 1994.
Ahmed I, et al. Proposal of Lysinibacillus boronitolerans gen. nov. sp. nov., and transfer of Bacillus fusiformis to Lysinibacillus fusiformis comb. nov. and Bacillus sphaericus to Lysinibacillus sphaericus comb. nov. Int. J. Syst. Evol. Microbiol. 57(Pt 5): 1117-1125, 2007. PubMed: 17473269
